HIIT in Isolated IFG: A Proof-of-Concept Study

NANot yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions
Isolated Impaired Fasting Glucose
Interventions
BEHAVIORAL

High-intensity interval training and eucaloric diet

Intervention participants will complete 24 supervised high-intensity interval training (HIIT) sessions over 8 weeks, with 3 sessions per week on alternate days. Each HIIT session will consist of a 5-minute warm-up, followed by an interval-based workout phase that includes steady up-tempo cadences, sprints, and climbs, interspersed with recovery periods. The session will conclude with a 5-minute cooldown. The workout sessions will initially last 20 minutes and will progressively increase in time based on participants\' tolerance and instructor recommendations. Intensity will start at 75% of estimated maximal heart rate reserve and will increase by 5% weekly, as tolerated and/or deemed necessary by the instructor, over the 8-week intervention period. Participants will receive instructions to maintain a eucaloric diet throughout the study.

BEHAVIORAL

No intense physical activity and eucaloric diet

Control participants will be instructed to refrain from engaging in intense physical activities during the study period. They will also receive instructions to maintain a eucaloric diet throughout the study.

DEVICE

Continuous glucose monitoring (CGM) (Dexcom G6 Pro CGM sensor)

The continuous glucose monitoring (CGM) system comprises a sensor, a transmitter, and a receiver. The sensor measures interstitial fluid glucose levels every 5 minutes, and the transmitter wirelessly sends this glucose data to the receiver. Both intervention and control participants will wear the CGM device in a blinded mode for 10 days before starting the intervention, throughout the 8-week intervention period, and for 10 days post-intervention.

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Emory University

OTHER

NCT06143345 - HIIT in Isolated IFG: A Proof-of-Concept Study | Biotech Hunter | Biotech Hunter